CytomX Therapeutics (CTMX) Other Working Capital Changes (2014 - 2026)
CytomX Therapeutics (CTMX) posted Other Working Capital Changes of -$9.6 million for Q1 2026, down 1844.46% on a QoQ basis from $551000.0 in Q4 2025, and up 78.46% year-over-year from -$5.4 million in Q1 2025.
CytomX Therapeutics (CTMX) Other Working Capital Changes (2014 - 2026) Analysis & Trends
CytomX Therapeutics' Other Working Capital Changes history runs 9 years deep, the most recent figure standing at -$9.6 million for Q1 2026.
- Quarterly Other Working Capital Changes rose 78.46% year-over-year to -$9.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$30.6 million (up 77.16% YoY) and the FY2025 annual result came in at -$65.6 million, up 44.53% from the prior year.
- Other Working Capital Changes was -$9.6 million for Q1 2026 at CytomX Therapeutics, down from $551000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $3.2 million in Q4 2022 and bottomed at -$1.6 million in Q2 2023.
- A 5-year average of $86000.0 and a median of -$1000.0 in 2022 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes jumped 543.47% — and 2023, when it plunged 159.63%.
- CytomX Therapeutics' Other Working Capital Changes stood at $45.9 million in 2022, then sank by 153.07% to -$24.3 million in 2023, then tumbled by 46.07% to -$35.6 million in 2024, then soared by 101.55% to $551000.0 in 2025, then slumped by 1844.46% to -$9.6 million in 2026.
- Business Quant data shows CTMX's Other Working Capital Changes at -$9.6 million in Q1 2026, $551000.0 in Q4 2025, and -$4.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | CytomX Therapeutics | 590.32 Mn | 243.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 887,000.00 |
| Mar 31, 2026 | 887,000.00 |
| Mar 31, 2026 | 887,000.00 |
| Dec 31, 2025 | 874,000.00 |
| Dec 31, 2025 | 874,000.00 |
| Dec 31, 2025 | 874,000.00 |
| Sep 30, 2025 | -708,000.00 |
| Sep 30, 2025 | -708,000.00 |
| Sep 30, 2025 | -708,000.00 |
| Jun 30, 2025 | -126,000.00 |
| Jun 30, 2025 | -126,000.00 |
| Jun 30, 2025 | -126,000.00 |
| Mar 31, 2025 | 1.20 Mn |
| Mar 31, 2025 | 1.20 Mn |
| Mar 31, 2025 | 1.20 Mn |
| Dec 31, 2024 | 335,000.00 |
| Dec 31, 2024 | 335,000.00 |
| Dec 31, 2024 | 335,000.00 |
| Sep 30, 2024 | 111,000.00 |
| Sep 30, 2024 | 111,000.00 |